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Abstract
Human papillomavirus 16 major capsid protein L1 (composed of 505 amino acids (aa) including 12 cysteines) assembles by itself into
virion-like icosahedral particles (L1-capsids), each of which is dissociated into 72 pentameric capsomeres when intermolecular disulfide
bonds are disrupted. To identify the cysteines affecting the bonding and the structural integrity of the L1-capsids, we constructed a series
of L1 mutants with substitution of serine for cysteine, which were expressed from recombinant baculoviruses in the insect Sf9 cells. From
infected cells, the self-assembled L1-capsid fractions were purified by CsCl-equilibrium centrifugation and examined for velocity
sedimentation profiles, for the presence of intermolecular bonding by SDS–PAGE with or without a reducing agent, for morphology under
an electron microscope, and for susceptibility to trypsin digestion. Mutants C175S (C at aa 175 was replaced with S) and C185S were
sedimented in sucrose-density gradients slightly slower than the wild type (WT) capsids, and mutant C428S stayed near the top as
WT-capsomeres did. In the nonreducing SDS gel, where WT-capsids were separated into two bands of L1-trimers and L1-dimers, the
C175S-trimer band was not detected, the C185S-dimer band was much less dense, and the C428S-trimer and C428S-dimer bands were not
detected. Thus, it seems likely that C175, C185, and C428 are involved in L1 trimerization, in L1 dimerization, and in both, respectively.
Morphologically, the C175S, C185S, and C428S fractions appeared to consist mostly of heterogeneous rod-shaped tubules, of smaller
spherical particles, and of only capsomeres, respectively, whereas C102S, C229S, and C379S resembled WT. The C161S, C175S, C185S,
C229S, C379S, and C428S capsids were more sensitive to degradation caused by trypsin than WT. The results indicate that C175, C185,
and C428 are required for the normal assembly of L1-capsids through trimerization and dimerization of L1 bound by the intercapsomeric
disulfide bonds between cysteines, and that C161, C229, and C379 are necessary for the integrity of L1-capsids probably through
intramolecular bonding.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Human papillomaviruses (HPVs), which cause a variety
of proliferating epithelial lesions including skin and cervical
cancers (zur Hausen, 1996), are classified into more than 80
genotypes from the sequence homology of 8-kb circular
genomic DNA (zur Hausen, 1996). A nonenveloped HPV
capsid containing viral DNA is an icosahedral particle with
a diameter of 55 nm, which is composed of major capsid
protein L1 and minor protein L2 (Pfister and Fuchs, 1994).
HPVs infect basal cells of the epithelium through microle-
sions and replicate only in the differentiating cells. These
cells are difficult to culture in vitro; hence, no tissue culture
system for the large-scale propagation of HPVs is available
at present.
To obtain HPV capsids in quantities sufficient for struc-
tural and other analyses, surrogate systems have been de-
veloped (Hagensee et al., 1994; Kawana et al., 1998; Kirn-
bauer et al., 1993; Matsumoto et al., 1997). Expression of
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L1 either alone or together with L2 from recombinant vac-
cinia viruses (Hagensee et al., 1994) or recombinant bacu-
loviruses results in production of self-assembled L1-capsids
(also called virus-like particle; VLP) (Hagensee et al., 1994;
Kirnbauer et al., 1993; Matsumoto et al., 1997) or L1/L2-
capsids (Kawana et al., 1998; Kirnbauer et al., 1993; Vol-
pers et al., 1994). These particles are morphologically in-
distinguishable under an electron microscope from HPV
virions extracted from the lesions (Hagensee et al., 1994).
An HPV capsid, with icosahedral symmetry (T  7),
consists of 72 capsomeres (Pfister and Fuchs, 1994). The
capsomere is a pentamer of L1 (Pfister and Fuchs, 1994).
The capsid probably contains 12 copies of L2 located at the
12 pentavalent capsomeres (Pfister and Fuchs, 1994). Since
reducing agents cause disassembly of the capsids to the
level of the capsomeres (Kawana et al., 1998; Li et al.,
1998; McCarthy et al., 1998), it has been indicated that
intercapsomeric disulfide bonds contribute to the assembly
of HPV capsids. Study of HPV 33 L1 mutants has identified
two cysteines required for the intercapsomeric disulfide
bonds (Sapp et al., 1998.).
In this study, we constructed and studied a series of HPV
16 L1 mutants with substitution of serine for cysteine to
determine which of 12 cysteines in the L1 (505 amino acids
(aa) long) contributes to the assembly and structural integ-
rity of L1-capsids. Purified wild-type (WT) and mutant
L1-capsid fractions (with a buoyant density of 1.27 g/ml)
from insect cells were subjected to analyses by sedimenta-
tion through sucrose density gradients, nonreducing SDS–
polyacrylamide electrophoresis (SDS–PAGE), electron mi-
croscopy, and digestion with trypsin. It was found that
cysteines at aa 175, 185, and 428 (C175, C185, and C428)
are involved in the intercapsomeric disulfide bonding and
the normal assembly of the L1-capsids, and that C229 and
C379 are probably involved in the intramolecular disulfide
bonding that contributes to the integrity of the L1-capsids.
Results
Expression of L1 in insect cells and purified L1-capsid
fractions
Twelve cysteines in the HPV16 L1 (Fig. 1) were re-
placed with serines, one by one, to generate 12 mutants. The
mutant was designated, for instance, C102S, in which cys-
teine at aa 102 (C102) was replaced with serine, and others
were designated accordingly. One mutant with two substi-
tutions at aa 175 and 185 was also constructed and desig-
nated C175S/C185S. Similar to WT L1, the L1 mutants
appeared to be stably expressed in Sf9 cells infected with
the recombinant baculoviruses. In immunoblotting with an-
ti-HPV 16 L1 antibody, levels of mutated L1s in total
extracts of the infected Sf9 cells were similar to that of WT
L1 (data not presented), indicating that the substitution
mutations did not affect stability of L1s in the insect cells.
The L1-capsid fractions were prepared from the infected
Sf9 cells by banding in CsCl gradients and used for the
subsequent analyses.
Sucrose density-gradient centrifugation analysis
Sedimentation patterns of the L1-capsid fractions were
compared in a sucrose density gradient (5–45%) between
Fig. 1. Alignment of L1 amino acid sequences of papillomaviruses. Numbers to the left represent human papillomavirus types, and BPV 1 and CRPV
represent bovine papillomavirus type 1 and cottontail rabbit papillomavirus, respectively. Numbers on the top represent amino acid numbers for cysteines
in HPV 16 L1 (positions in L1), starting from the N-terminus. The number of total amino acids constituting each L1 is shown to the right. The positions of
cysteines in L1s are as follow. HPV 31: 103, 147, 158, 162, 176, 186, 226, 230, 325, 346, 380, 429; HPV 33: 103, 147, 158, 162, 176, 185, 207, 225, 229,
324, 345, 378, 427; HPV52: 131, 175, 186, 190, 204, 214, 236, 254, 258, 355, 376, 409, 458; HPV58: 6, 7, 14, 129, 173, 184, 188, 202, 211, 233, 251, 255,
350, 371, 404, 453; HPV18: 2, 42, 163, 218, 222, 236, 246, 279, 286, 290, 310, 350, 385, 406, 441, 490; HPV6b: 99, 153, 157, 171, 181, 221, 225, 320,
341, 374, 423; HPV11: 99, 154, 158, 172, 182, 222, 226, 321, 342, 375, 424; HPV1a: 166, 179, 189, 233, 323, 331, 365, 435; HPV2a: 3, 117, 174, 188,
197, 237, 241, 335, 356, 389, 438; HPV5: 103, 161, 164, 175, 185, 229, 246, 255, 395, 444; BPV1: 22, 157, 171, 181, 225, 377, 426, 473; CRPV: 99, 161,
175, 185, 201, 296, 328, 385, 436.
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WT and the substitution mutants (C102S, C146S, C157S,
C161S, C175S, C185S, C225S, C229S, C324S, C345S,
C379S, and C428S). For comparison with capsids, WT
capsomeres were prepared by incubating the purified WT
L1-capsid fraction with 2-ME (5%) at 4°C for 16 h. After
the WT capsids and capsomeres were centrifuged in paral-
lel, each fraction was examined by SDS–PAGE followed by
immunoblotting. When probed with anti-L1 antibody, the
capsids and capsomeres were found to peak near the bottom
and the top of the centrifuge tube, respectively (Fig. 2A).
The WT and mutants were compared under these condi-
tions.
Except for mutants C175S, C185S, and C428S, all the
other mutants showed a similar sedimentation pattern to that
of WT L1-capsids (Fig. 2B). Mutants C175S and C185S
sedimented slightly slower than the WT capsids, and mutant
C428S behaved similar to capsomeres. These abnormal
sedimentation patterns were reproducible in several inde-
pendent experiments. The results suggest that C175, C185,
and C428 are likely to be involved in L1-capsid formation
in the cells.
Because the sedimentation patterns suggest C175S and
C185S capsids, if they are made, may be abnormal as
compared with WT, a double-mutant C175S/C185S was
constructed and purified to test the combined effects of the
two mutations. The sedimentation pattern resembled none
of those of the WT and single mutants and showed dual
peaks in the gradient, suggesting the presence of capsid-like
and capsomere-like structures (Fig. 2B).
SDS–PAGE under nonreducing or reducing conditions
In the presence of SDS and 2-ME, capsomeres are dis-
assembled into L1-monomers, but in the absence of 2-ME
the intercapsomeric disulfide bonding can be retained and
thus nonreducing SDS–PAGE is thought to reveal the bond-
ing between cysteines on different molecules. Under non-
reducing conditions, purified WT-capsids were separated
into two distinctive bands with apparent molecular masses
of 180 and 120 kDa, respectively (Fig. 3A). When the
sample was incubated with increasing 2-ME concentrations
before the electrophoresis, these bands gradually shifted to
the position of 57 kDa, the size of L1 monomer (Fig. 3A).
The data indicate that the 180 and 120 kDa proteins corre-
spond to L1-trimers and L1-dimers, respectively. Because
the monomer was not detected in the nonreducing condi-
tions, it was indicated that the dimer was not derived from
the trimer by partial cleavage of the disulfide bonds. The
presence of trimers and dimers, therefore, is likely to reflect
the state of the intercapsomeric bonding within the L1-
capsids.
Except for mutants C175S, C185S, C428S, and C175S/
185S, all the other mutants behaved similar to WT L1
capsids in nonreducing SDS–PAGE (Fig. 3B). Mutant
C175S showed no trimer band. C185S showed a dimer band
much less dense than its trimer band; C428S showed mostly
a monomer band, and C175S/C185S resembled C175S (Fig.
3B). In reducing conditions, WT and all the mutants showed
only a 57-kDa monomer band (Fig. 3C). Thus, it was con-
cluded that C175, C185, and C428 are involved in the
intermolecular disulfide bonding to form the L1-trimers,
L1-dimers, and both in the nonreducing conditions, respec-
tively.
Electron microscopy of particles formed by L1-mutants
The WT and selected mutant L1-capsid fractions
(C102S, C161S, C175S, C185S, C229S, C379S, C428S,
and C175S/C185S) were examined under a transmission
electron microscope (Fig. 4). WT, C102S, C229S, and
C379S contained spherical L1-capsids with a diameter of 55
nm. C175S consisted mainly of heterogeneous rod-shaped
tubular structures. C185S capsid-like particles were mostly
smaller than WT, with diameters of 40 to 55 nm. C175S/
C185S consisted of irregularly shaped particles appearing
rather similar to aggregates. C428S contained only capsom-
eres. It is, therefore, clear that C175, C185, and C428 are
involved in the normal assembly of L1-capsids.
Degradation of L1-capsids by digestion with trypsin
In an attempt to detect possible subtle changes in the
capsid structure, we examined the mutant L1-capsids for
their sensitivity to trypsin digestion. Purified L1-capsids
were incubated with trypsin (final concentration of 1 ng/l)
for the indicated periods at 37°C in a buffer of pH 7.5, and
the degradation products were detected by SDS–PAGE fol-
lowed by immunoblotting (Fig. 5). Clearly the C175S,
C428S, and C175S/C185S capsids were degraded rapidly.
Comparison of the relative level of 57kDa (full-length L1)
and 53 kDa (the degradation product) at 60 min shows that
the C161S, C185S, C229S, and C379S capsids were more
sensitive to trypsin digestion than WT-capsids. The 45 kDa
degradation product is only detected where the L1 does not
assemble into spherical structure. Of those more sensitive to
trypsin than WT, C175S, C185S, and C428S showed ab-
normal morphology, but C161S, C229S, and C379S mor-
phologically resembled WT (Fig. 4). The latter two mutants,
therefore, are likely to have some structural changes unde-
tectable by electron microscopy but revealed as susceptibil-
ity to trypsin digestion.
Discussion
In this study we identified five cysteines, of 12 distrib-
uted in HPV16 L1 composed of 505 aa (Fig. 1), as those
affecting the assembly and/or structural integrity of L1-
capsids. The three cysteines, C175, C185, and C428, are
required for formation of intercapsomeric disulfide bonds
and for normal assembly of L1-capsids (Figs. 2, 3, and 4).
The two cysteins, C229 and C379, though not involved in
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Fig. 2. Sedimentation analyses of WT and mutant L1-capsid fractions. (A) Purified WT L1-capsids (WT) and capsomeres obtained by disruption of the
capsids with 2-ME (WT  2ME) were loaded on the 5 to 45% linear sucrose-density gradient and centrifuged. After fractionation, each aliquot was
electrophoresed in SDS–polyacrylamide gel (10%) and was subjected to immunoblotting for detection of HPV 16 L1. (B) Purified mutant L1-capsid fractions
were analyzed similarly by the sucrose-density gradient centrifugation followed by the immunoblotting.
Fig. 3. Nonreducing and reducing SDS–PAGE analyses of WT and mutant L1-capsids. (A) The purified WT L1-capsids were suspended in the nonreducing
SDS sample buffer (see Materials and methods) plus 2-ME (0 to 0.08%) and boiled for 10 min. The samples were electrophoresed in SDS–polyacrylamide
gel (8%) followed by the immunoblotting to detect L1. The apparent molecular masses of marker proteins are indicated to the left. (B) The purified WT and
mutant L1-capsid fractions were suspended in the nonreducing SDS sample buffer, boiled for 10 min, and electrophoresed in SDS–polyacrylamide gel (8%)
followed by the immunoblotting to detect L1. (C) The purified mutated L1s were suspended in the standard SDS sample buffer and boiled for 10 min. The
samples were subjected to SDS–PAGE (8% gel) followed by the immunoblotting to detect HPV 16 L1. The apparent molecular masses of marker proteins
are indicated to the left.
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the intercapsomeric bonding and the capsid assembly, are
required for the capsid integrity (Fig. 5). It may be that the
intramolecular bonding associated with C229 or C379 helps
maintain the integrity of L1-capsids, as revealed by suscep-
tibility to trypsin, although it remains unclear at present how
to correlate the susceptibility to the subtle structural changes
of the capsid.
The substitution for C175 appeared to inhibit L1 trimer-
ization and formation of spherical particles, suggesting that
the former is required by the latter. The substitution for
C185 appeared to inhibit L1 dimerization, which is proba-
bly required for correct assembly of capsomeres in forming
uniform spherical particles. The substitution for C428
showed the strongest inhibitory effects, inhibition of L1
trimerization and dimerization, and of forming any capsid-
like structures. C428 seems to play a critical role in con-
necting capsomeres together to keep any higher order struc-
tures. It should be noted that lack of the trimerization and
dimerization did not affect capsomere formation as ob-
served with C428S. According to the X-ray crystallographic
Fig. 4. Electron micrographs of purified WT and mutant L1-capsid fractions. Scale bar represents 50 nm.
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analysis of the capsid-like structures composed of HPV 16
L1 (Chen et al., 2000), the three cysteines are thought to be
localized in the loops displayed on the surface. This is
consistent with our conclusion that these cysteines are in-
volved in intercapsomeric disulfide bonds.
Although it is not clear which pairs of the cysteines
would make the intercapsomeric disulfide bonds for correct
assembly of capsids, C428 may participate in intercapsom-
eric bonding of all capsomeres, and C175 and C185 may be
involved in bonding the complex of three and two capsom-
eres, respectively. Two types of junctions of capsomeres
may be necessary to form an icosahedral structure com-
posed of pentavalent and hexavalent capsomeres (Chen et
al., 2000; Trus et al., 1997).
The importance of C175 and C428 in HPV 16 L1 is
consistent with the results of the studies of cysteine
mutants of HPV11 (Li et al., 1998) and of HPV 33 (Sapp
et al., 1998). The HPV11 mutant with substitution of
glycine for cysteine at aa 424, which corresponds to
C428S in this study, does not assemble into capsids (Li et
al., 1998). The two HPV 33 mutants with substitution of
serine for cysteine at aa 176 and aa 427, which corre-
spond to C175S and C428S, respectively, have lost their
capability to self-assemble into capsids. However, some
of the results obtained with HPV 16 do not agree with
those obtained with HPV 33. First, in the nonreducing
SDS–PAGE, HPV 33 WT capsids have yielded two
bands of L1-trimers and L1-monomers with a ratio of 1:1,
but no band of L1-dimers. In the similar analysis in this
study, HPV 16 WT capsids yielded two bands of L1-
trimers and L1-dimers, but no band of L1-monomers.
Second, whereas the mutant of aa 176 of HPV 33 have
formed only capsomeres, C175S of HPV 16 assembled
into the rod-shaped tubular structures. It remains to be
clarified whether the discrepancy between the two studies
is ascribable to the intrinsic genetic difference between
HPV 33 and HPV 16 or to a yet unidentified difference in
experimental conditions between the studies or to both.
The locations of cysteines are well-conserved in the L1
proteins from various human, bovine, and cottontail rabbit
papillomaviruses (Fig. 1). Among these L1s consisting of
approximately 500 aa, the relative positions of cysteines are
markedly similar. Particularly, those corresponding to
C161, C175, C185, C229, C379, and C428 of HPV 16 L1
are shared by the human and animal papillomaviruses
(though CRPV appears to lack a C229 equivalent), which
strongly suggests our findings in this study are likely to be
applicable to the other papillomaviruses as well.
Materials and methods
Construction of DNA fragments encoding WT and L1
mutants
A DNA fragment containing HPV-16 L1 ORF (nucleo-
tides 5637 to 7154; the HPV Sequence Database of Los
Alamos National Laboratory) was prepared by PCR using
sense primer with NotI site, antisense primer with XbaI site,
and the previously produced HPV 16 DNA clone (nucleo-
tides 6240 is G) (Matsumoto et al., 1997). Substitution
mutations were introduced into the DNA by using an oli-
gonucleotide-directed mutagenesis kit (Takara Shuzo, Co.
Ltd., Kyoto, Japan). Twelve cysteine codons in the L1 gene
(Fig. 1) were replaced with serine codons, one by one, to
generate 12 mutants. Codons for serine, TGT and TGC,
were replaced with AGT and AGC, respectively. The mu-
tations were confirmed by DNA sequencing.
Fig. 5. Degradation of purified WT and mutant L1-capsid fractions with trypsin. The purified capsid fractions were incubation with trypsin (final concentration
of 1 ng/l) for the indicated periods and then electrophoresed in SDS–polyacrylamide gel (8%) followed by immunoblotting. Degradation products were
detected by staining with anti-L1 antibody.
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Construction of recombinant baculoviruses expressing WT
and L1 mutants
The recombinant baculovirus capable of expressing L1
was constructed by the use of Bac system including plasmid
pFastBac (GIBCO-BRL Inc., New York, NY). The DNA
fragment with L1 ORF was inserted into the downstream of
the polyhedrin promoter of plasmid pFastBac1. The recom-
binant plasmid was introduced into Escherichia coli
DH10Bac-competent cells that contain Bacmid DNA with a
mini-attTn7 target site and the helper plasmid. The resultant
recombinant Bacmid DNA was purified and transfected into
Sf9 cells, which were grown in SFM medium supplemented
with 3% fetal calf serum (FCS) at 27°C. The recombinant
baculovirus that was propagated in the Sf9 cells transfected
with the Bacimid was used as a seed for large-scale pro-
duction of L1-capsids.
Preparation of purified WT and mutant L1-capsid
fractions
L1 and L1 mutants were expressed in insect Sf-9 cells
from recombinant baculoviruses with the DNA fragment
containing L1 ORF. Sf9 cells (four bottles of 175-cm2
culture flask) were infected with the seed of the recombinant
baculovirus and incubated for 4 days at 27°C. The cells
were collected and suspended in 4 ml PBS containing 0.5%
NP-40. After 15 min incubation at RT, the cells were cen-
trifuged at 10,000 g at 4°C for 15 min to precipitate nuclei.
The nuclei were suspended in CsCl in PBS (1.27 g/ml)
containing the protease inhibitor cocktail (Roche Diagnos-
tics Co. Ltd., Mannheim, Germany) and lysed with brief
sonication. The solution was centrifuged at 34,000 rpm for
20 h with an SW50.1 rotor (Beckman Coulter Inc., Fulleron,
CA). The fractions around a buoyant density of 1.27 g/ml,
which contain L1-capsids, were pooled and dialyzed against
PBS at 4°C overnight to remove CsCl. The resulting mate-
rial (CsCl-purified L1-capsid fraction) was used for the
analysis by sucrose density-gradient centrifugation imme-
diately after digestion with DNase I under the conditions as
described below. (DNase I digestion was incorporated in the
purification procedure because the presence of DNA caused
aggregation of capsids or capsid-like structures of some
mutants.)
For analyses by nonreducing SDS–PAGE, degradation
with trypsin, and electron microscopy, the CsCl-purified
material was further digested with DNase I in the presence
of protease inhibitors and was then banded by centrifugation
in a sucrose solution. After addition of MgCl2, the protease
inhibitor cocktail, and DNase I (Takara Shuzo Co. Ltd.), the
material was diluted with PBS to adjust concentration of L1
to 0.5 g/l, and MgCl2 to 2.5 mM, the protease inhibitors
to the appropriate concentration recommended by the man-
ufacturer, and DNase I to 1.4 units/l. After incubation for
30 min at 37°C, the material was applied on the top of two
layers of 5 and 50% sucrose in TS-buffer (50 mM Tris–HCl,
pH 7.4 and 150 mM NaCl) and centrifuged at 120,000 g for
2.5 h at 4°C with an SW40.1 rotor (Beckman Coulter Inc.).
The interface of the two layers was collected and dialyzed
against phosphate buffer containing NaCl (0.5 M) and used
as the purified L1-capsid fraction for the analyses.
SDS–PAGE and immunoblotting
Samples were suspended in the standard SDS sample
buffer (153 mM Tris–HCl, pH 7.5, 4.9% SDS, 6.13%
2-mercaptoethanol (2-ME), 24.5% glycerol, and 0.0025%
bromphenol blue), boiled for 10 min, and electrophoresed in
SDS–polyacrylamide gel (8 or 10%). Proteins in the gel
were transferred to a nylon membrane, Hybond-P (Amer-
sham Biosciences Inc., Uppsala, Sweden). After blocking
with 5% skim milk, L1 on the membrane was probed by
anti-HPV 16 L1 mouse monoclonal antibody (554171, Bec-
ton–Dickinson Co. Ltd., San Diego, CA). Horseradish per-
oxidase conjugated anti-mouse IgG goat antibodies (SC-
2031, Santa Cruz Biotechnology, Inc., Santa Cruz, CA) and
ECL Western Blotting Detection System (Amersham Bio-
sciences Inc.) were used to detect mouse IgG on the mem-
brane.
Sucrose density-gradient centrifugation
The purified L1-capsid fraction (100 l) was layered on
the top of a 5 to 45% linear sucrose-density gradient in TS
buffer (50 mM Tris–HCl, pH 7.4, 150 mM NaCl) and
centrifuged at 120,000 g for 2.5 h at 4°C with an SW50.1
rotor (Beckman Coulter Inc.). Aliquots (160 l each) were
collected from the tube bottom. Three microliters of each
fraction was mixed with 27 l of the standard SDS sample
buffer and was analyzed by SDS–PAGE followed by the
immunoblotting.
Nonreducing SDS–PAGE
The purified L1-capsid fractions were boiled for 10 min
in the standard SDS sample buffer without 2-ME and elec-
trophoresed in 8% SDS–polyacrylamide gel. L1 that mi-
grated in the gel was detected by the immunoblotting.
Electron microscopy
The purified L1-capsid fractions were allowed to settle
on carbon-coated copper grids and stained with 4% urany-
lacetate. The grids were examined in a Hitachi model
H-7600 transmission electron microscope and photographed
at an instrumental magnification of 200,000.
Degradation by trypsin
The purified L1-capsid fraction (5 l) was diluted at 1 to
10 with a buffer of 200 mM Tris–HCl, pH 7.5, 150 mM
NaCl and received trypsin (final concentration of 1 ng/l).
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The reaction mixture was incubated at 37°C for 15, 30, or
60 min, mixed with an equal volume of the SDS sample
buffer (twice concentrated), and then boiled immediately.
The sample was subjected to SDS–PAGE followed by im-
munoblotting with anti-L1 antibody.
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